Zobrazeno 1 - 10
of 21
pro vyhledávání: '"W. G. Bensen"'
Autor:
M R, McClung, P, Geusens, P D, Miller, H, Zippel, W G, Bensen, C, Roux, S, Adami, I, Fogelman, T, Diamond, R, Eastell, P J, Meunier, J Y, Reginster
Publikováno v:
The New England journal of medicine. 344(5)
Risedronate increases bone mineral density in elderly women, but whether it prevents hip fracture is not known.We studied 5445 women 70 to 79 years old who had osteoporosis (indicated by a T score for bone mineral density at the femoral neck that was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ee8f405a55e36ca5fce75b8e1dfedf38
https://pubmed.ncbi.nlm.nih.gov/11386284
https://pubmed.ncbi.nlm.nih.gov/11386284
Autor:
W G, Bensen, S Z, Zhao, T A, Burke, R A, Zabinski, R W, Makuch, C J, Maurath, N M, Agrawal, G S, Geis
Publikováno v:
The Journal of rheumatology. 27(8)
To determine the upper gastrointestinal (GI) tolerability of celecoxib, naproxen, and placebo in patients with rheumatoid arthritis (RA) and osteoarthritis (OA).An analysis of 5, 12-week, randomized, double blind, parallel group, placebo controlled c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f44775d1723f9070c3de3864a4d36708
https://pubmed.ncbi.nlm.nih.gov/10955327
https://pubmed.ncbi.nlm.nih.gov/10955327
Autor:
E M Woods, J I McMillen, J J Fiechtner, Richard C. Hubbard, Shawn S. Yu, Kenneth M. Verburg, G S Geis, W G Bensen, Peter C. Isakson, W W Zhao
Publikováno v:
Mayo Clinic proceedings. 74(11)
Objective To compare the efficacy and safety of celecoxib, a cyclooxygenase-2 (COX-2) inhibitor, with those of naproxen, a nonsteroidal anti-inflammatory drug (NSAID), and placebo in the treatment of osteoarthritis of the knee. Methods In this multic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8682442f7a3a134daf54776c4736984
https://pubmed.ncbi.nlm.nih.gov/10560596
https://pubmed.ncbi.nlm.nih.gov/10560596
Autor:
R J, Sebaldt, G, Ioannidis, J D, Adachi, W G, Bensen, F, Bianchi, A, Cividino, M, Gordon, E, Kaminska, T, Scocchia, A, Petrie, G F, Stephenson, C H, Goldsmith
Publikováno v:
The Journal of rheumatology. 26(7)
To determine the longterm safety and efficacy of etidronate therapy in patients in whom corticosteroid induced bone loss has already occurred.We performed a 36 month observational cohort study in which all data were obtained from Canadian Database of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d4fe2af5e661ae36c2f3f94f0bb2801f
https://pubmed.ncbi.nlm.nih.gov/10405943
https://pubmed.ncbi.nlm.nih.gov/10405943
Autor:
J D, Adachi, M J, Bell, W G, Bensen, F, Bianchi, A, Cividino, R J, Sebaldt, M, Gordon, G, Ioannidis, C, Goldsmith
Publikováno v:
The Journal of rheumatology. 24(12)
To determine the efficacy of sodium fluoride (40 mg/day) in preventing rheumatoid arthritis (RA) induced bone loss, which may lead to osteoporosis.We conducted an 18 month, randomized, double blind, placebo controlled trial in 38 patients with RA. Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ba189898b92e14d8017c7703b22642f8
https://pubmed.ncbi.nlm.nih.gov/9415633
https://pubmed.ncbi.nlm.nih.gov/9415633
Autor:
J D, Adachi, W G, Bensen, F, Bianchi, A, Cividino, S, Pillersdorf, R J, Sebaldt, P, Tugwell, M, Gordon, M, Steele, C, Webber, C H, Goldsmith
Publikováno v:
The Journal of rheumatology. 23(6)
To determine the efficacy and safety of vitamin D 50,000 units/week and calcium 1,000 mg/day in the prevention of corticosteroid induced osteoporosis.A minimized double blind, placebo controlled trial in corticosteroid treated subjects in a tertiary
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2777c9762ca3a2bd0b9612e69c7b3888
https://pubmed.ncbi.nlm.nih.gov/9035007
https://pubmed.ncbi.nlm.nih.gov/9035007
Autor:
N, Bellamy, W G, Bensen, A, Beaulieu, K A, Siminovitch, G R, Kraag, A, Lussier, S, Ahmad, V N, Khanna, P, Davis, M J, Bell
Publikováno v:
The Journal of rheumatology. 22(5)
To conduct the first Canadian study of the comparative efficacy and safety of nabumetone and diclofenac SR in patients with primary osteoarthritis (OA) of the hip, knee and shoulder.Nabumetone 1000-1500 mg po daily was compared to diclofenac SR 100-1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::53fc0394b34dffe844222f8199211847
https://pubmed.ncbi.nlm.nih.gov/8587082
https://pubmed.ncbi.nlm.nih.gov/8587082
Publikováno v:
Clinical and investigative medicine. Medecine clinique et experimentale. 15(5)
A six week, double-blind, randomized, parallel group, multicentre study was conducted in 85 patients with osteoarthritis of the knee and hip to compare the efficacy, tolerability, and safety of Flurbiprofen-SR 200 mg with Diclofenac Sodium-SR 100 mg.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7be166c951f7817f94ac4a1f90a7a6a2
https://pubmed.ncbi.nlm.nih.gov/1458715
https://pubmed.ncbi.nlm.nih.gov/1458715
Publikováno v:
The Journal of rheumatology. 19(4)
We assessed the effect of the prostaglandin E1 analog misoprostol on cyclosporine nephrotoxicity in patients with rheumatoid arthritis (RA). Thirteen patients with RA were given cyclosporine with misoprostol tablets, 800 micrograms/day for one week i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ed6d4377d82e29fcbcdf0ad8ddade8b6
https://pubmed.ncbi.nlm.nih.gov/1593573
https://pubmed.ncbi.nlm.nih.gov/1593573
Autor:
A A, Long, J S, Ginsberg, P, Brill-Edwards, M, Johnston, C, Turner, J A, Denburg, W G, Bensen, A, Cividino, M, Andrew, J, Hirsh
Publikováno v:
Thrombosis and haemostasis. 66(5)
In order to determine whether an association exists between antiphospholipid antibodies (APLA) and thromboembolic events in patients with systemic lupus erythematosus (SLE), we performed a cross-sectional study of consecutive unselected SLE patients.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a0934eee4d7c40f7cf8f11329acbc523
https://pubmed.ncbi.nlm.nih.gov/1803614
https://pubmed.ncbi.nlm.nih.gov/1803614